imipramine has been researched along with MS (Multiple Sclerosis) in 9 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colombo, F | 1 |
| Bastoni, M | 1 |
| Nigro, A | 1 |
| Podini, P | 1 |
| Finardi, A | 1 |
| Casella, G | 1 |
| Ramesh, M | 1 |
| Farina, C | 1 |
| Verderio, C | 1 |
| Furlan, R | 1 |
| Pollak, Y | 1 |
| Orion, E | 1 |
| Goshen, I | 1 |
| Ovadia, H | 1 |
| Yirmiya, R | 1 |
| McGuire, EJ | 1 |
| Savastano, JA | 1 |
| Okiishi, CG | 1 |
| Paradiso, S | 1 |
| Robinson, RG | 1 |
| Rabey, JM | 1 |
| Moriel, EZ | 1 |
| Farkas, A | 1 |
| Firstater, M | 1 |
| Vardi, I | 1 |
| Streifler, M | 1 |
| Cendrowski, W | 1 |
| Jameson, RM | 1 |
| Dean, G | 1 |
| Gottschalk, LA | 1 |
| Gleser, GC | 1 |
| Wylie, HW | 1 |
| Kaplan, SM | 1 |
2 reviews available for imipramine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'.
Topics: Animals; Antidepressive Agents, Tricyclic; Cytokines; Depressive Disorder; Disease Models, Animal; E | 2002 |
Gender differences in depression associated with neurologic illness: clinical correlates and pharmacologic response.
Topics: Alzheimer Disease; Amitriptyline; Antidepressive Agents, Tricyclic; Depression; Epilepsy; Female; Hu | 2001 |
2 trials available for imipramine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
A double-blind trial with an antidepressant drug, imipramine, in multiple sclerosis.
Topics: Clinical Trials as Topic; Depression; Humans; Imipramine; Multiple Sclerosis; Placebos; Spasm | 1969 |
Effects of imipramine on anxiety and hostility levels.
Topics: Adult; Anxiety; Clinical Trials as Topic; Fear; Guilt; Hate; Humans; Hypochondriasis; Imipramine; Ma | 1965 |
5 other studies available for imipramine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Cytokines Stimulate the Release of Microvesicles from Myeloid Cells Independently from the P2X7 Receptor/Acid Sphingomyelinase Pathway.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell-Derived Microparticles; Cytokines; Encephalomyeliti | 2018 |
Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction.
Topics: Adult; Aged; Bethanechol; Bethanechol Compounds; Female; Humans; Imipramine; Male; Mandelic Acids; M | 1984 |
Detrusor hyperreflexia in multiple sclerosis. Alleviation by a combination of imipramine and propantheline, a clinico-laboratory study.
Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Mu | 1979 |
[Attempts at pharmacological and surgical treatment of intentional and postural tremor in patients with disseminated sclerosis (authors transl)].
Topics: Adult; Amitriptyline; Evaluation Studies as Topic; Female; Humans; Imipramine; Male; Middle Aged; Mu | 1976 |
Management of the bladder in non-traumatic paraplegia.
Topics: Amitriptyline; Female; Humans; Imipramine; Male; Multiple Sclerosis; Myelitis; Neoplasm Metastasis; | 1974 |